| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9027db61aa0660b01fa94e3bd560a3df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7b7bb7575fed2a1956a21dc7fba4b72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_548321aef9616669815514a1c78527c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e97ac6cec4a40bad89b3f57ad28093c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c99a6d1cb9b19d5a05826c82acb1a203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a2c0bc93a77499a4c02e76ca551c06 |
| publicationDate |
2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03061386-A1 |
| titleOfInvention |
Wt1 antisense oligos for the inhibition of breast cancer |
| abstract |
The present invention provides methods for inhibiting the growth of breast cancer cells and methods for treating breast cancers expressing Wilms' Tumor 1 (WT1) gene product using a WT1 antisense oligonucleotide. It further provides methods of predicting breast cancer progression and methods for the screening of candidate substances for activity against breast cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1738771-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1738771-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299234-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005024060-A1 |
| priorityDate |
2002-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |